LncRNAs and neoplasia

Clinica Chimica Acta

Volumn 444, Issue , 2015, Pages 280-288

  Isin, Mustafa ^a   Dalay, Nejat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cancer; LncRNA; Non coding RNA

Indexed keywords

BIOLOGICAL MARKER; GROWTH ARREST SPECIFIC 5; HOX TRANSCRIPT ANTISENSE INTERGENIC RNA; LINCRNA P21; LONG UNTRANSLATED RNA; MATERNALLY EXPRESSED 3; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; RNA ANRIL; RNA H19; UNCLASSIFIED DRUG; TUMOR MARKER;

ALTERNATIVE RNA SPLICING; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; EPIGENETICS; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA ANALYSIS; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; GENETICS; METABOLISM; NEOPLASMS; PROGNOSIS;

BIOMARKERS, TUMOR; HUMANS; NEOPLASMS; PROGNOSIS; RNA, LONG NONCODING;

EID: 84924705800     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.02.046     Document Type: Review

References (210)

1. Sanchez Y., Huarte M. Long non-coding RNAs: challenges for diagnosis and therapies. Nucleic Acid Ther 2013, 23:15-20.
2. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136:629-641.
3. Mercer T.R., Dinger M.E., Sunkin S.M., Mehler M.F., Mattick J.S. Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci U S A 2008, 105:716-721.
4. Pauli A., Valen E., Lin M.F., Garber M., Vastenhouw N.L., Levin J.Z., et al. Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis. Genome Res 2012, 22:577-591.
5. Mattick J.S. The genetic signatures of noncoding RNAs. PLoS Genet 2009, 5:e1000459.
6. Gibb E.A., Vucic E.A., Enfield K.S., Stewart G.L., Lonergan K.M., Kennett J.Y., et al. Human cancer long non-coding RNA transcriptomes. PLoS One 2011, 6:e25915.
7. Gutschner T., Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012, 9:703-719.
8. Ma L., Bajic V.B., Zhang Z. On the classification of long non-coding RNAs. RNA Biol 2013, 10:924-933.
9. Cui Z., Ren S., Lu J., Wang F., Xu W., Sun Y., et al. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Urol Oncol 2013, 31:1117-1123.
10. Takayama K., Horie-Inoue K., Katayama S., Suzuki T., Tsutsumi S., Ikeda K., et al. Androgen responsive long noncoding RNA CTBP1-AS promotes prostate cancer. EMBO J 2013, 32:1665-1680.
11. Kino T., Hurt D.E., Ichijo T., Nader N., Chrousos G.P. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal 2010, (3):ra8.
12. Martens-Uzunova E.S., Jalava S.E., Dits N.F., van Leenders G.J., Møller S., Trapman J., et al. Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer. Oncogene 2012, 31:978-991.
13. Fu V.X., Schwarze S.R., Kenowski M.L., Leblanc S., Svaren J., Jarrard D.F. A loss of insulin-like growth factor-2 imprinting is modulated by CCCTC-binding factor down-regulation at senescence in human epithelial cells. J Biol Chem 2004, 279:52218-52226.
14. Fu V.X., Dobosy J.R., Desotelle J.A., Almassi N., Ewald J.A., Srinivasan R., et al. Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate. Cancer Res 2008, 68:6797-6802.
15. Lin R., Maeda S., Liu C., Karin M., Edgington T.S. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007, 26:851-858.
16. Bussemakers M.J., van Bokhoven A., Verhaegh G.W., Smit F.P., Karthaus H.F., Schalken J.A., et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 1999, 59:5975-5979.
17. Crawford E.D., Rove K.O., Trabulsi E.J., Qian J., Drewnowska K.P., Kaminetsky J.C., et al. Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases. J Urol 2012, 188:1726-1731.
18. Prensner J.R., Iyer M.K., Balbin O.A., Dhanasekaran S.M., Cao Q., Brenner J.C., et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol 2011, 29:742-749.
19. Srikantan V., Zou Z., Petrovics G., Xu L., Augustus M., Davis L., et al. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Natl Acad Sci U S A 2000, 97:12216-12221.
20. Petrovics G., Zhang W., Makarem M., Street J.P., Connelly R., Sun L., et al. Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene 2004, 23:605-611.
21. Xue Y., Wang M., Kang M., Wang Q., Wu B., Chu H., et al. Association between lncrna PCGEM1 polymorphisms and prostate cancer risk. Prostate Cancer Prostatic Dis 2013, 16:139-144.
22. Ifere G.O., Ananaba G.A. Prostate cancer gene expression marker 1 (PCGEM1): a patented prostate-specific non-coding gene and regulator of prostate cancer progression. Recent Pat DNA Gene Seq 2009, 3:151-163.
23. Ifere G.O., Barr E., Equan A., Gordon K., Singh U.P., Chaudhary J., et al. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines. Cancer Detect Prev 2009, 32:319-328.
24. Fu X., Ravindranath L., Tran N., Petrovics G., Srivastava S. Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol 2006, 25:135-141.
25. Yang L., Lin C., Jin C., Yang J.C., Tanasa B., Li W., et al. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature 2013, 500:598-602.
26. Chung S., Nakagawa H., Uemura M., Piao L., Ashikawa K., Hosono N., et al. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci 2011, 102:245-252.
27. Poliseno L., Salmena L., Zhang J., Carver B., Haveman W.J., Pandolfi P.P. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010, 465:1033-1038.
28. Johnsson P., Ackley A., Vidarsdottir L., Lui W.O., Corcoran M., Grandér D., et al. A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol 2013, 20:440-446.
29. Hudson R.S., Yi M., Volfovsky N., Prueitt R.L., Esposito D., Volinia S., et al. Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer 2013, 12:13.
30. Laner T., Schulz W.A., Engers R., Muller M., Florl A.R. Hypomethylation of the XIST gene promoter in prostate cancer. Oncol Res 2005, 15:257-264.
31. Song M.A., Park J.H., Jeong K.S., Park D.S., Kang M.S., Lee S. Quantification of CpG methylation at the 50-region of XIST by pyrosequencing from human serum. Electrophoresis 2007, 28:2379-2384.
32. Pasmant E., Sabbagh A., Vidaud M., Bièche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 2011, 25:444-448.
33. Chi Y., Huang S., Yuan L., Liu M., Huang N., Zhou S., et al. Role of BC040587 as a predictor of poor outcome in breast cancer. Cancer Cell Int 2014, 14:123.
34. Xing Z., Lin A., Li C., Liang K., Wang S., Liu Y., et al. lncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell 2014, 159:1110-1125.
35. Iacoangeli A., Lin Y., Morley E.J., Muslimov I.A., Bianchi R., Reilly J., et al. BC200 RNA in invasive and preinvasive breast cancer. Carcinogenesis 2004, 25:2125-2133.
36. Liu D., Rudland P.S., Sibson D.R., Barraclough R. Identification of mRNAs differentially-expressed between benign and malignant breast tumour cells. Br J Cancer 2002, 87:423-431.
37. Mourtada-Maarabouni M., Pickard M.R., Hedge V.L., Farzaneh F., Williams G.T. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009, 28:195-208.
38. Qi P., Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol 2013, 26:155-165.
39. Sørensen K.P., Thomassen M., Tan Q., Bak M., Cold S., Burton M., et al. Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res Treat 2013, 142:529-536.
40. Ding X., Zhu L., Ji T., Zhang X., Wang F., Gan S., et al. Long intergenic non-coding RNAs (LincRNAs) identified by RNA-seq in breast cancer. PLoS One 2014, 9:e103270.
41. Shi Y., Lu J., Zhou J., Tan X., He Y., Ding J., et al. Long non-coding RNA Loc554202 regulates proliferation and migration in breast cancer cells. Biochem Biophys Res Commun 2014, 446:448-453.
42. Silva J.M., Boczek N.J., Berres M.W., Ma X., Smith D.I. LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol 2011, 8:496-505.
43. Zhang X., Zhou Y., Mehta K.R., Danila D.C., Scolavino S., Johnson S.R., et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab 2003, 88:5119-5126.
44. Augoff K., McCue B., Plow E.F., Sossey-Alaoui K. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer 2012, 11:5.
45. Lipovich L., Johnson R., Lin C.Y. MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. Biochim Biophys Acta 2010, 1799:597-615.
46. Guan Y., Kuo W.L., Stilwell J.L., Takano H., Lapuk A.V., Fridlyand J., et al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 2007, 13:5745-5755.
47. Borth N., Massier J., Franke C., Sachse K., Saluz H.P., Hänel F. Chlamydial protease CT441 interacts with SRAP1 co-activator of estrogen receptor alpha and partially alleviates its co-activation activity. J Steroid Biochem Mol Biol 2010, 119:89-95.
48. Vincent-Salomon A., Ganem-Elbaz C., Manié E., Raynal V., Sastre-Garau X., Stoppa-Lyonnet D., et al. X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors. Cancer Res 2007, 67:5134-5140.
49. Askarian-Amiri M.E., Crawford J., French J.D., Smart C.E., Smith M.A., Clark M.B., Ru K., Mercer T.R., Thompson E.R., Lakhani S.R., Vargas A.C., Campbell I.G., Brown M.A., Dinger M.E., Mattick J.S. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA 2011 May, 17(5):878-891.
50. Qiu M., Xu Y., Yang X., Wang J., Hu J., Xu L., et al. CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumour Biol 2014, 35:5375-5380.
51. Ono H., Motoi N., Nagano H., Miyauchi E., Ushijima M., Matsuura M., et al. Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer. Cancer Med 2014, 3:632-642.
52. Huarte M., Guttman M., Feldser D., Garber M., Koziol M.J., Kenzelmann-Broz D., et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010, 142:409-419.
53. Nie F.Q., Zhu Q., Xu T.P., Zou Y.F., Xie M., Sun M., et al. Long non-coding RNA MVIH indicates a poor prognosis for non-small cell lung cancer and promotes cell proliferation and invasion. Tumour Biol 2014, 35:7587-7594.
54. Ji P., Diederichs S., Wang W., Böing S., Metzger R., Schneider P.M., et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22:8031-8041.
55. Komiya K., Sueoka-Aragane N., Sato A., Hisatomi T., Sakuragi T., Mitsuoka M., et al. Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells. J Cancer Res Clin Oncol 2010, 136(3):465-473.
56. Zhang E.B., Yin D.D., Sun M., Kong R., Liu X.H., You L.H., et al. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis 2014, 5:e1243.
57. Nissan A., Stojadinovic A., Mitrani-Rosenbaum S., Halle D., Grinbaum R., Roistacher M., et al. Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues. Int J Cancer 2012, 130:1598-1606.
58. He X., Tan X., Wang X., Jin H., Liu L., Ma L., et al. c-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumour Biol 2014, 35:12181-12188.
59. Graham L.D., Pedersen S.K., Brown G.S., Ho T., Kassir Z., Moynihan A.T., et al. Colorectal neoplasia differentially expressed (CRNDE), a novel gene with elevated expression in colorectal adenomas and adenocarcinomas. Genes Cancer 2011, 2:829-840.
60. Matouk I.J., Abbasi I., Hochberg A., Galun E., Dweik H., Akkawi M. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol 2009, 21:688-692.
61. Hrdlickova B., de Almeida R.C., Borek Z., Withoff S. Genetic variation in the non-coding genome: involvement of micro-RNAs and long non-coding RNAs in disease. Biochim Biophys Acta 1842, 2014:1910-1922.
62. Nakano S., Murakami K., Meguro M., Soejima H., Higashimoto K., Urano T., et al. Expression profile of LIT1/KCNQ1OT1 and epigenetic status at the KvDMR1 in colorectal cancers. Cancer Sci 2006, 97:1147-1154.
63. Zhai H., Fesler A., Schee K., Fodstad O., Flatmark K., Ju J. Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer. Clin Colorectal Cancer 2013, 12:261-266.
64. Wang G., Li Z., Zhao Q., Zhu Y., Zhao C., Li X., et al. LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway. Oncol Rep 2014, 31:1839-1845.
65. Yang F., Huo X.S., Yuan S.X., Zhang L., Zhou W.P., Wang F., et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell 2013, 49:1083-1096.
66. Xu C., Yang M., Tian J., Wang X., Li Z. MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int J Oncol 2011, 39:169-175.
67. Qi P., Xu M.D., Ni S.J., Shen X.H., Wei P., Huang D., et al. Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients. Mol Carcinog Feb 12 2014, [Epub ahead of print]. 10.1002/mc-22137.
68. Yap K.L., Li S., Muñoz-Cabello A.M., Raguz S., Zeng L., Mujtaba S., Gil J., et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 2010, 38:662-674.
69. Hombach S., Kretz M. The non-coding skin: exploring the roles of long non-coding RNAs in epidermal homeostasis and disease. Bioessays 2013, 35:1093-1100.
70. Valls J., Solé X., Hernández P., Cerrato C., Madrigal I., de Cid R., et al. Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor. Genes Chromosomes Cancer 2007, 46:155-162.
71. Khaitan D., Dinger M.E., Mazar J., Crawford J., Smith M.A., Mattick J.S., et al. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res 2011, 71:3852-3862.
72. He W., Cai Q., Sun F., Zhong G., Wang P., Liu H., et al. linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer. Biochim Biophys Acta 2013, 1832:1528-1537.
73. Ariel I., Sughayer M., Fellig Y., Pizov G., Ayesh S., Podeh D., Libdeh B.A., Levy C., Birman T., Tykocinski M.L., de Groot N., Hochberg A. The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Pathol 2000, 53:320-323.
74. Fan Y., Shen B., Tan M., Mu X., Qin Y., Zhang F., Liu Y. TGF-β-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res 2014, 20:1531-1541.
75. Ying L., Huang Y., Chen H., Wang Y., Xia L., Chen Y., et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst 2013, 9:407-411.
76. Zhu Y., Yu M., Li Z., Kong C., Bi J., Li J., et al. ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival. Urology 2011, 77(510):e1-e5.
77. Han Y., Liu Y., Gui Y., Cai Z. Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder. J Surg Oncol 2013, 107:555-559.
78. Wang F., Li X., Xie X., Zhao L., Chen W. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett 2008, 582:1919-1927.
79. Fan Y., Shen B., Tan M., Mu X., Qin Y., Zhang F., Liu Y. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J 2014, 281:1750-1758.
80. Eis P.S., Tam W., Sun L., Chadburn A., Li Z., Gomez M.F., et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 2005, 102:3627-3632.
81. Qiao H.P., Gao W.S., Huo J.X., Yang Z.S. Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. Asian Pac J Cancer Prev 2013, 14:1077-1082.
82. Frevel M.A., Sowerby S.J., Petersen G.B., Reeve A.E. Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor. J Biol Chem 1999, 274:29331-29340.
83. Bertozzi D., Iurlaro R., Sordet O., Marinello J., Zaffaroni N., Capranico G. Characterization of novel antisense HIF-1α transcripts in human cancers. Cell Cycle 2011, 10:3189-3197.
84. Pandey R.R., Mondal T., Mohammad F., Enroth S., Redrup L., Komorowski J., et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell 2008, 32:232-246.
85. Zhang H.M., Yang F.Q., Chen S.J., Che J., Zheng J.H. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Tumour Biol Dec 6 2014, [Epub ahead of print]. 10.1007/s13277-014-2925-6.
86. Kawakami T., Chano T., Minami K., Okabe H., Okada Y., Okamoto K. Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma. Hum Mol Genet 2006, 15:821-830.
87. He H., Nagy R., Liyanarachchi S., Jiao H., Li W., Suster S., et al. A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 2009, 69:625-631.
88. Wang Y., Guo Q., Zhao Y., Chen J., Wang S., Hu J., et al. BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma. Oncol Lett 2014, 8:1947-1952.
89. Jendrzejewski J., He H.L., Radomska H.S., Li W., Tomsic J., Liyanarachchi S., et al. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc Natl Acad Sci U S A 2012, 109:8646-8651.
90. Baldinu P., Cossu A., Manca A., Satta M.P., Sini M.C., Rozzo C., et al. Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer. Hum Mutat 2004, 23:318-326.
91. Huang J., Ke P., Guo L., Wang W., Tan H., Liang Y., et al. Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo. Int J Gynecol Cancer 2014, 24:635-642.
92. Yamada K., Kano J., Tsunoda H., Yoshikawa H., Okubo C., Ishiyama T., et al. Phenotypic characterization of endometrial stromal sarcoma of the uterus. Cancer Sci 2006, 97:106-112.
93. Yu W., Gius D., Onyango P., Muldoon-Jacobs K., Karp J., Feinberg A.P., et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 2008, 451:202-206.
94. Mertens D., Philippen A., Ruppel M., Allegra D., Bhattacharya N., Tschuch C., et al. Chronic lymphocytic leukemia and 13q14: miRs and more. Leuk Lymphoma 2009, 50:502-505.
95. Liu Y., Corcoran M., Rasool O., Ivanova G., Ibbotson R., Grandér D., et al. Cloning of two candidate tumor suppressor genes within a 10kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene 1997, 15:2463-2473.
96. Benetatos L., Hatzimichael E., Dasoula A., Dranitsaris G., Tsiara S., Syrrou M., et al. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res 2010, 34:148-153.
97. Thompson R.C., Vardinogiannis I., Gilmore T.D. Identification of an NF-κB p50/p65-responsive site in the human MIR155HG promoter. BMC Mol Biol 2013, 14:24.
98. Saitou M., Sugimoto J., Hatakeyama T., Russo G., Isobe M. Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemia. Oncogene 2000, 19:2796-2802.
99. Dallosso A.R., Hancock A.L., Malik S., Salpekar A., King-Underwood L., Pritchard-Jones K., et al. Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer. RNA 2007, 13:2287-2299.
100. Tahira A.C., Kubrusly M.S., Faria M.F., Dazzani B., Fonseca R.S., Maracaja-Coutinho V., et al. Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Mol Cancer 2011, 10:141.
101. You L., Chang D., Du H.Z., Zhao Y.P. Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells. Biochem Biophys Res Commun 2011, 407:1-6.
102. Brannan C.I., Dees E.C., Ingram R.S., Tilghman S.M. The product of the H19 gene may function as an RNA. Mol Cell Biol 1990, 10:28-36.
103. Brown C.J., Ballabio A., Rupert J.L., Lafreniere R.G., Grompe M., Tonlorenzi R., et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 1991, 349:38-44.
104. Flicek P., Amode M.R., Barrell D., Beal K., Brent S., Carvalho-Silva D., et al. Ensembl 2012. Nucleic Acids Res 2012, 40:D84-D90.
105. Bu D., Yu K., Sun S., Xie C., Skogerbø G., Miao R., et al. NONCODE v3.0: integrative annotation of long noncoding RNAs. Nucleic Acids Res 2012, 40:D210-D215.
106. Xie C., Yuan J., Li H., Li M., Zhao G., Bu D., et al. NONCODEv4: exploring the world of long non-coding RNA genes. Nucleic Acids Res 2014, 42:D98-D103.
107. Volders P.J., Helsens K., Wang X., Menten B., Martens L., Gevaert K., et al. LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res 2013, 41:D246-D251.
108. Bhartiya D., Pal K., Ghosh S., Kapoor S., Jalali S., Panwar B., et al. lncRNome: a comprehensive knowledgebase of human long noncoding RNAs. Database (Oxford) 2013, 2013:bat034.
109. Chen G., Wang Z., Wang D., Qiu C., Liu M., Chen X., et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res 2013, 41:D983-D986.
110. Jia H., Osak M., Bogu G.K., Stanton L.W., Johnson R., Lipovich L. Genome-wide computational identification and manual annotation of human long noncoding RNA genes. RNA 2010, 16:1478-1487.
111. Zhao J., Sun B.K., Erwin J.A., Song J.J., Lee J.T. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 2008, 322:750-756.
112. Hung T., Wang Y., Lin M.F., Koegel A.K., Kotake Y., Grant G.D., et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 2011, 43:621-629.
113. Bazzini A.A., Johnstone T.G., Christiano R., Mackowiak S.D., Obermayer B., Fleming E.S., et al. Identification of small ORFs in vertebrates using ribosome foot printing and evolutionary conservation. EMBO J 2014, 33:981-993.
114. Juntawong P., Girke T., Bazin J., Bailey-Serres J. Translational dynamics revealed by genome-wide profiling of ribosome footprints in Arabidopsis. Proc Natl Acad Sci U S A 2014, 111:E203-E212.
115. Guttman M., Russell P., Ingolia N.T., Weissman J.S., Lander E. Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins. Cell 2013, 154:240-251.
116. Ruiz-Orera J., Messeguer X., Subirana J.A., Alba M.M. Long non-coding RNAs as a source of new peptides. Elife 2014, 16(3):e03523.
117. Feng J., Bi C., Clark B.S., Mady R., Shah P., Kohtz J.D. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev 2006, 20:1470-1484.
118. Bond A.M., Vangompel M.J., Sametsky E.A., Clark M.F., Savage J.C., Disterhoft J.F., et al. Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nat Neurosci 2009, 12:1020-1027.
119. Shamovsky I., Ivannikov M., Kandel E.S., Gershon D., Nudler E. RNA-mediated response to heat shock in mammalian cells. Nature 2006, 440:556-560.
120. Lanz R.B., McKenna N.J., Onate S.A., Albrecht U., Wong J., Tsai S.Y., et al. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 1999, 97:17-27.
121. Wang X., Arai S., Song X., Reichart D., Du K., Pascual G., et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008, 454:126-130.
122. Tripathi V., Shen Z., Chakraborty A., Giri S., Freier S.M., Wu X., et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet 2013, 9:e1003368.
123. Krystal G.W., Armstrong B.C., Battey J.F. N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts. Mol Cell Biol 1990, 10:4180-4191.
124. Li K., Blum Y., Verma A., Liu Z., Pramanik K., Leigh N.R., et al. A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. Blood 2010, 115:133-139.
125. Munroe S.H., Lazar M.A. Inhibition of c-erbA mRNA splicing by a naturally occurring antisense RNA. J Biol Chem 1991, 266:22083-22086.
126. Hastings M.L., Milcarek C., Martincic K., Peterson M.L., Munroe S.H. Expression of the thyroid hormone receptor gene, erbAalpha, in B lymphocytes: alternative mRNA processing is independent of differentiation but correlates with antisense RNA levels. Nucleic Acids Res 1997, 25:4296-4300.
127. Beltran M., Puig I., Pena C., Garcia J.M., Alvarez A.B., Pena R., et al. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev 2008, 22:756-769.
128. Faghihi M.A., Modarresi F., Khalil A.M., Wood D.E., Sahagan B.G., Morgan T.E., et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 2008, 14:723-730.
129. Jiang Y., Mullaney K.A., Peterhoff C.M., Che S., Schmidt S.D., Boyer-Boiteau A., et al. Alzheimer's-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc Natl Acad Sci U S A 2010, 107:1630-1635.
130. Faghihi M.A., Zhang M., Huang J., Modarresi F., Van der Brug M.P., Nalls M.A., et al. Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol 2010, 11:R56.
131. Levanon E.Y., Eisenberg E., Yelin R., Nemzer S., Hallegger M., Shemesh R., et al. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotechnol 2004, 22:1001-1005.
132. Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 2010, 79:321-349.
133. Clemson C.M., Hutchinson J.N., Sara S.A., Ensminger A.W., Fox A.H., Chess A., et al. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell 2009, 33:717-726.
134. Kanduri C., Thakur N., Pandey R.R. The length of the transcript encoded from the Kcnq1ot1 antisense promoter determines the degree of silencing. EMBO J 2006, 25:2096-2106.
135. Monnier P., Martinet C., Pontis J., Stancheva I., Ait-Si-Ali S., Dandolo L. H19 lncRNA controls gene expression of the Imprinted Gene Network by recruiting MBD1. Proc Natl Acad Sci U S A 2013, 110:20693-20698.
136. Hatta Y., Hirama T., Miller C.W., Yamada Y., Tomonaga M., Koeffler H.P. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood 1995, 85:2699-2704.
137. Otsuki T., Jaffe E.S., Wellmann A., Kumar S., Condron K.S., Raffeld M. Absence of p18 mutations or deletions in lymphoid malignancies. Leukemia 1996, 10:356-360.
138. Martinez-Delgado B., Robledo M., Arranz E., Osorio A., García M.J., Echezarreta G., et al. Hypermethylation of p15/ink4b/MTS2 gene is differentially implicated among non-Hodgkin's lymphomas. Leukemia 1998, 12:937-941.
139. Maloney K.W., McGavran L., Odom L.F., Hunger S.P. Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations. Leukemia 1998, 12:1417-1421.
140. Bernstein E., Allis C.D. RNA meets chromatin. Genes Dev 2005, 19:1635-1655.
141. Guttman M., Rinn J.L. Modular regulatory principles of large non-coding RNAs. Nature 2012, 482:339-346.
142. Wang K.C., Chang H.Y. Molecular mechanisms of long noncoding RNAs. Mol Cell 2011, 43:904-914.
143. Mattick J.S., Amaral P.P., Dinger M.E., Mercer T.R., Mehler M.F. RNA regulation of epigenetic processes. Bioessays 2009, 31:51-59.
144. Khalil A.M., Guttman M., Huarte M., Garber M., Raj A., Rivea Morales D., et al. Many human large intergenic noncoding RNAs associate with chromatin modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 2009, 106:11667-11672.
145. Schuettengruber B., Martinez A.M., Iovino N., Cavalli G. Trithorax group proteins: switching genes on and keeping them active. Nat Rev Mol Cell Biol 2011, 12:799-814.
146. Bracken A.P., Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer 2009, 9:773-784.
147. Lee J.T., Bartolomei M.S. X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell 2013, 152:1308-1323.
148. Lessing D., Anguera M.C., Lee J.T. X chromosome inactivation and epigenetic responses to cellular reprogramming. Annu Rev Genomics Hum Genet 2013, 14:85-110.
149. Lee J.T. Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome. Genes Dev 2009, 23:1831-1842.
150. Lee J.T. Gracefully ageing at 50, X-chromosome inactivation becomes a paradigm for RNA and chromatin control. Nat Rev Mol Cell Biol 2011, 12:815-826.
151. Tsai M.C., Manor O., Wan Y., Mosammaparast N., Wang J.K., Lan F., et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329:689-693.
152. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
153. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323.
154. Hindorff L.A., Sethupathy P., Junkins H.A., Ramos E.M., Mehta J.P., Collins F.S., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009, 106:9362-9367.
155. Jin G., Sun J., Isaacs S.D., Wiley K.E., Kim S.T., Chu L.W., et al. Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk. Carcinogenesis 2011, 32:1655-1659.
156. Guo W., Dong Z., Bai Y., Guo Y., Shen S., Kuang G., et al. Associations between polymorphisms of HOTAIR and risk of gastric cardia adenocarcinoma in a population of north China. Tumour Biol Dec 5 2014, [Epub ahead of print]. 10.1007/s13277-014-2912-y.
157. Zhou W., Tao Z., Wang Z., Hu W., Shen M., Zhou L., et al. Long noncoding RNA PCA3 gene promoter region is related to the risk of prostate cancer on Chinese males. Exp Mol Pathol 2014, 97:550-553.
158. Liu Y., Pan S., Liu L., Zhai X., Liu J., Wen J., et al. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One 2012, 7:e35145.
159. Li L., Sun R., Liang Y., Pan X., Li Z., Bai P., et al. Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of colorectal cancer. J Exp Clin Cancer Res 2013, 32:104.
160. Wang L., Zeng X., Chen S., Ding L., Zhong J., Zhao J.C., et al. BRCA1 is a negative modulator of the PRC2 complex. EMBO J 2013, 32:1584-1597.
161. Zhuang Y., Wang X., Nguyen H.T., Zhuo Y., Cui X., Fewell C., et al. Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen. J Hematol Oncol 2013, 6:35.
162. Chen F.J., Sun M., Li S.Q., Wu Q.Q., Ji L., Liu Z.L., et al. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog 2013, 52:908-915.
163. Yang Z., Zhou L., Wu L.M., Lai M.C., Xie H.Y., Zhang F., et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 2011, 18:1243-1250.
164. Kogo R., Shimamura T., Mimori K., Kawahara K., Imoto S., Sudo T., et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 2011, 71:6320-6326.
165. Kim K., Jutooru I., Chadalapaka G., Johnson G., Frank J., Burghardt R., et al. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 2013, 32:1616-1625.
166. Geng Y.J., Xie S.L., Li Q., Ma J., Wang G.Y. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res 2011, 39:2119-2128.
167. Yu F.J., Zheng J.J., Dong P.H., Fan X.M. Long non-coding RNAs and hepatocellular carcinoma. Mol Clin Oncol 2015, 3:13-17.
168. Popov N., Gil J. Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health. Epigenetics 2010, 5:685-690.
169. Cunnington M.S., Santibanez Koref M., Mayosi B.M., Burn J., Keavney B. Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet 2010, 6:e1000899.
170. Stacey S.N., Sulem P., Masson G., Gudjonsson S.A., Thorleifsson G., Jakobsdottir M., et al. New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 2009, 41:909-914.
171. Iacobucci I., Sazzini M., Garagnani P., Ferrari A., Boattini A., Lonetti A., et al. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia. Leuk Res 2011, 35:1052-1059.
172. Rajaram V., Knezevich S., Bove K.E., Perry A., Pfeifer J.D. DNA sequence of the translocation breakpoints in undifferentiated embryonal sarcoma arising in mesenchymal hamartoma of the liver harboring the t(11;19)(q11;q13.4) translocation. Genes Chromosomes Cancer 2007, 46:508-513.
173. Tripathi V., Ellis J.D., Shen Z., Song D.Y., Pan Q., Watt A.T., et al. The nuclear retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 2010, 39:925-938.
174. Luo J.H., Ren B., Keryanov S., Tseng G.C., Rao U.N., Monga S.P., et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 2006, 44:1012-1024.
175. Müller-Tidow C., Diederichs S., Thomas M., Serve H. Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer. Lung Cancer 2004, 45:S145-S150.
176. Tano K., Mizuno R., Okada T., Rakwal R., Shibato J., Masuo Y., et al. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 2010, 584:4575-4580.
177. Ying L., Chen Q., Wang Y., Zhou Z., Huang Y., Qiu F. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst 2012, 8:2289-2294.
178. Huarte M., Rinn J.L. Large non-coding RNAs: missing links in cancer?. Hum Mol Genet 2010, 19:R152-R161.
179. Maruyama R., Suzuki H. Long noncoding RNA involvement in cancer. BMB Rep 2012, 45:604-611.
180. Hauptman N., Glavač D. Long non-coding RNA in cancer. Int J Mol Sci 2013, 14:4655-4669.
181. Qin R., Chen Z., Ding Y., Hao J., Hu J., Guo F. Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. Neoplasma 2013, 60:486-492.
182. Tu Z.Q., Li R.J., Mei J.Z., Li X.H. Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma. Int J Clin Exp Pathol 2014, 7:4303-4309.
183. Cao S., Liu W., Li F., Zhao W., Qin C. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer. Int J Clin Exp Pathol 2014, 7:6776-6783.
184. Wang P., Ren Z., Sun P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J Cell Biochem 2012, 113:1868-1874.
185. Astuti D., Latif F., Wagner K., Gentle D., Cooper W.N., Catchpoole D., et al. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br J Cancer 2005, 92:1574-1580.
186. Braconi C., Kogure T., Valeri N., Huang N., Nuovo G., Costinean S., et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011, 30:4750-4756.
187. Yan J., Guo X., Xia J., Shan T., Gu C., Liang Z., et al. MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1. Med Oncol 2014, 31:879.
188. Sheng X., Li J., Yang L., Chen Z., Zhao Q., Tan L., et al. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer. Oncol Rep 2014, 32:277-285.
189. Zhou Y., Zhang X., Klibanski A. MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol 2012, 48:R45-R53.
190. Gabory A., Jammes H., Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays 2010, 32:473-480.
191. Hibi K., Nakamura H., Hirai A., Fujikake Y., Kasai Y., Akiyama S., et al. Loss of H19 imprinting in esophageal cancer. Cancer Res 1996, 56:480-482.
192. Matouk I.J., DeGroot N., Mezan S., Ayesh S., Abu-lail R., Hochberg A., et al. The H19 non-coding RNA is essential for human tumor growth. PLoS One 2007, 2:e845.
193. Berteaux N., Lottin S., Monté D., Pinte S., Quatannens B., Coll J., et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem 2005, 280:29625-29636.
194. Tsang W.P., Ng E.K., Ng S.S., Jin H., Yu J., Sung J.J., et al. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 2010, 31:350-358.
195. Barsyte-Lovejoy D., Lau S.K., Boutros P.C., Khosravi F., Jurisica I., Andrulis I.L., et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res 2006, 66:5330-5337.
196. Yang F., Bi J., Xue X., Zheng L., Zhi K., Hua J., et al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J 2012, 279:3159-3165.
197. Yoshimizu T., Miroglio A., Ripoche M.A., Gabory A., Vernucci M., Riccio A., et al. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci U S A 2008, 105:12417-12422.
198. Zhang S., Chen S., Yang G., Gu F., Li M., Zhong B., et al. Long noncoding RNA HOTAIR as an independent prognostic marker in cancer: a meta-analysis. PLoS One 2014, 9:e105538.
199. Cai B., Wu Z., Liao K., Zhang S. Long noncoding RNA HOTAIR can serve as a common molecular marker for lymph node metastasis: a meta-analysis. Tumour Biol 2014, 35:8445-8450.
200. Panzitt K., Tschernatsch M.M., Guelly C., Moustafa T., Stradner M., Strohmaier H.M., et al. Characterization of HULC, a novel gene with striking upregulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007, 132:330-342.
201. de Kok J.B., Verhaegh G.W., Roelofs R.W., Hessels D., Kiemeney L.A., Aalders T.W., et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res 2002, 62:2695-2698.
202. Tinzl M., Marberger M., Horvath S., Chypre C. DD3PCA3 RNA analysis in urine-a new perspective for detecting prostate cancer. Eur Urol 2004, 46:182-186.
203. Hessels D., Klein Gunnewiek J.M., van Oort I., Karthaus H.F., van Leenders G.J., van Balken B., et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003, 44:8-15.
204. Shao Y., Chen H., Jiang X., Chen S., Li P., Ye M., et al. Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances. Tumour Biol 2014, 35:9591-9595.
205. Xu C., Shao Y., Xia T., Yang Y., Dai J., Luo L., et al. lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis. Tumour Biol 2014, 35:9701-9706.
206. Chen S., Li P., Xiao B., Guo J. Long noncoding RNA HMlincRNA717 and AC130710 have been officially named as gastric cancer associated transcript 2 (GACAT2) and GACAT3, respectively. Tumour Biol 2014, 35:8351-8352.
207. Gutschner T., Hämmerle M., Eissmann M., Hsu J., Kim Y., Hung G., et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2013, 73:1180-1189.
208. Niinuma T., Suzuki H., Nojima M., Nosho K., Yamamoto H., Takamaru H., et al. Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res 2012, 72:1126-1136.
209. Isin M., Ozgur E., Cetin G., Erten N., Aktan M., Gezer U., et al. Investigation of circulating lncRNAs in B-cell neoplasms. Clin Chim Acta 2014, 431:255-259.
210. Huang K.C., Rao P.H., Lau C.C., Heard E., Ng S.K., Brown C., et al. Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther 2002, 1:769-776.